iBio Inc (IBIO)
1.77
-0.12
(-6.35%)
USD |
NYAM |
Apr 18, 16:00
1.78
+0.01
(+0.56%)
After-Hours: 20:00
iBio Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2021 | 2.045M |
| June 30, 2021 | 2.371M |
| March 31, 2021 | 3.00M |
| December 31, 2020 | 2.331M |
| September 30, 2020 | 1.94M |
| June 30, 2020 | 1.638M |
| March 31, 2020 | 1.313M |
| December 31, 2019 | 1.744M |
| September 30, 2019 | 2.081M |
| June 30, 2019 | 2.018M |
| March 31, 2019 | 1.314M |
| December 31, 2018 | 0.865M |
| September 30, 2018 | 0.367M |
| June 30, 2018 | 0.444M |
| March 31, 2018 | 0.50M |
| December 31, 2017 | 0.459M |
| September 30, 2017 | 0.381M |
| June 30, 2017 | 0.394M |
| March 31, 2017 | 0.522M |
| December 31, 2016 | 0.864M |
| September 30, 2016 | 0.923M |
| June 30, 2016 | 0.948M |
| March 31, 2016 | 0.989M |
| December 31, 2015 | 0.959M |
| September 30, 2015 | 1.192M |
| Date | Value |
|---|---|
| June 30, 2015 | 1.851M |
| March 31, 2015 | 1.74M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | 1.347M |
| June 30, 2012 | 1.277M |
| March 31, 2012 | 1.27M |
| December 31, 2011 | 1.074M |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | |
| December 31, 2009 | |
| September 30, 2009 | |
| June 30, 2009 | 1.177M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.313M
Minimum
Mar 2020
3.00M
Maximum
Mar 2021
2.048M
Average
2.032M
Median
Revenue (TTM) Benchmarks
| Lixte Biotechnology Holdings Inc | -- |
| PAVmed Inc | 2.452M |
| Avalo Therapeutics Inc | 1.925M |
| Imunon Inc | -- |
| Ocugen Inc | -- |